March 20, 2020
Some patients with cancer are more vulnerable than others, said Jeffrey Patton, MD, acting chief executive officer and president of physician services of OneOncology, as well as chief executive office of Tennessee Oncology, which is down to its last 14-day supply of personal protective equipment.
March 07, 2020
As we move from the mono-therapy era into the combination era, we have to think of new arrangements, perhaps value-based arrangements that will work with the payers and the manufacturers so that patients will have access to these drugs and also have the best ability to get value from them, said Lee Schwartzberg, MD, FACP, chief medical officer and board member at OneOncology.
March 03, 2020
How can community oncology practices keep up with changing federal regulations and the constant fl ow of new scientific evidence, while delivering quality care in the era of payment reform? The answer, said panelists at Patient-Centered Oncology Care®, is to stay independent by working together.
March 03, 2020
Payers have a crucial role in the future of community oncology, said Jeffery Patton, MD, of OneOncology, because it’s in their interest to help this lower-cost option thrive.
February 26, 2020
While there are similarities to the Oncology Care Model, the new model has features “that could have a substantial impact on practices that choose to participate,” the authors write.
Provider Perspective: Stephen M. Schleicher, MD, MBA, Addresses Accountability Versus Control in Oncology Care First
December 16, 2019
An article Schleicher co-wrote in JAMA Oncology, which appeared the day before the announcement of Oncology Care First, offered insights into the need for changes to the original OCM.
December 04, 2019
In today’s Managed Care Cast, we bring you portions of the panel discussion during the the last Institute for Value-Based Medicine® (IVBM®) event for 2019, where oncologists and others shared their thoughts, successes, and frustrations with the current Oncology Care Model, as well as the question and answer session.
November 21, 2019
The momentum that OneOncology has in the marketplace creates an exciting environment for those involved, and those seeking to become involved, in our organization, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
November 20, 2019
Using market-research information builds comprehension of the communities OneOncology treats, which allows us to implement effective technologies for value-based care, said Robin Shah, chief commercial officer of OneOncology.
November 19, 2019
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses the importance of working with physicians to make sure they're comfortable prescribing biosimilars.
November 12, 2019
Providing providers with relevant data on quality of care and profitability allows them to adjust their practices efficiently, said Erich Mounce, chief operating officer, OneOncology.
November 08, 2019
Consolidating unified interests for improved cancer care can enhance efficiency and quality of care for patients, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
November 05, 2019
Oncology care groups have praised the multipayer Oncology Care Model (OCM) for transforming cancer care through greater focus on care navigation, palliative care, survivorship, and keeping patients out of the emergency department. But there are complaints that practices can be penalized for elements beyond their control—notably, the soaring cost of state-of-the-art immunotherapies that were not on the market when the OCM was conceived.
November 05, 2019
We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer, said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center.
November 04, 2019
Utilizing data, that we have generated from software solutions in our partnerships or use, will allow OneOncology to pair each practice center with effective technology, said Robin Shah, chief commercial officer of OneOncology.
October 28, 2019
Even without input from the Oncology Care Model, community practices can measure performance data through a robust electronic medical record like Flatiron, said Erich Mounce, chief operating officer, OneOncology.
October 27, 2019
Greater impact from programs like 340B and site-neutrality, as well as, an emphasis on the economies of scale and economies of intelligence, can assist community oncology practices in delivering high-quality care, said Tracy Bahl, MBA, president and chief executive officer of OneOncology.
October 22, 2019
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, looks back on the first year of OneOncology and discusses what's to come in the next year.
Erich Mounce: Partnerships and Performance Data Can Initiate Sustainable Growth in Clinical Practice
October 14, 2019
Initiating sustainable growth in clinical practices can be difficult, but through economies of scale derived from partnerships and performance data collection, optimal care can be administered efficiently, said Erich Mounce, chief operating officer, OneOncology.
October 03, 2019
Jeff Patton, MD, chief executive officer of Tennessee Oncology, weighs in on Oncology Care Model (OCM) performance period 4 results and taking on 2-sided risk.
August 08, 2019
Weeks after the first 2 anticancer biosimilars entered the US market, OneOncology announced that its partner practices have already started administering the drugs.
July 09, 2019
OneOncology has announced that is is entering a long-term strategic relationship with AmerisourceBergen to offer high-quality cancer care to patients across the country.
June 04, 2019
OneOncology has announced 3 new appointments to its executive team, bringing in experience to clinical, technological, and financial operations.
May 23, 2019
Through OneOncology, we will be able to identify best practices and support patients throughout the continuum of care, explained Jeff Patton, MD, chief executive officer of Tennessee Oncology.
May 19, 2019
Alliances are going to help community oncology participate in things that, as individual practices, they don‘t have the opportunity to do, said Barry Russo, chief executive officer of The Center for Cancer and Blood Disorders.
May 18, 2019
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains how partnerships like OneOncology can help community practices adapt to the rapidly changing cancer care and diagnostic landscape.
May 08, 2019
OneOncology is entering a new partnership with Arizona Blood & Cancer Specialists, a newly formed oncology group.
May 08, 2019
Jeff Patton, MD, chief executive officer of Tennessee Oncology, offers his reaction to CMS' proposal to ease restrictions on how Part D managed the 6 protected classes of drugs.
May 07, 2019
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, explains reimbursement challenges that community settings face with access to multigene testing.
May 02, 2019
In September 2018, Tennessee Oncology, New York Cancer and Blood Specialists, and West Cancer Center announced the launch of OneOncology. During the 2019 Community Oncology Conference, we sat down with Jeff Patton, MD, chief executive officer of Tennessee Oncology, and Robin Shah, chief development and marketing officer for OneOncology.
April 23, 2019
Lee Schwartzberg, MD, FACP, executive director, West Cancer Center, discusses his thoughts on calls for every person diagnosed with breast cancer to receive a multigene panel.
April 22, 2019
While the physician shortage is having an impact in rural areas, the impact of physician burnout is happening across the board, said Jeff Patton, MD, chief executive officer of Tennessee Oncology.
April 09, 2019
Jeff Patton, MD, chief executive officer of Tennessee Oncology, discusses results from Oncology Care Model (OCM) performance period 3 (PP3) and challenges his practice still experiences with the model.
April 08, 2019
Oncology needs to learn to use technology not just for keeping medical records, but also for caring for patients, explained Erich Mounce, chief operating officer, OneOncology.
April 06, 2019
Step therapy, which requires that patients try the payer’s preferred treatment before the one a physician recommends, is harmful to both sides of the doctor-patient relationship, according to Lee B. Schwartzberg, MD, medical director of the West Cancer and Research Institute, who spoke at the 2019 Community Oncology Conference, held in Orlando, Florida.
April 06, 2019
As the technology improves, we’re going to see liquid biopsies used in multiple different cancers, explained Lee Schwartzberg, MD, FACP, executive director, West Cancer Center.
April 01, 2019
OneOncology has tapped Lee Schwartzberg, MD, medical director of West Cancer Center and Research Institute and professor of medicine at The University of Tennessee Health Science Center as its chief medical officer.
March 23, 2019
Erich Mounce, chief operating officer, OneOncology, drew on his experience from West Cancer Center to discuss how community oncology can improve access to care and other inequalities in cancer care.
January 16, 2019
Moving from a comfortable place to one with new paths, new experiences, and new goals is both challenging and invigorating at the same time. Good fortune is when you choose to change because the future belongs to those who adapt.
December 10, 2018
Former Tennessee US senator, heart and lung transplant surgeon, and healthcare entrepreneur brings dynamic expertise to the OneOncology national network.
November 13, 2018
Former chief exeutive officer of the West Cancer Center brings over 3 decades of technology, operations, and care advancement to the OneOncology National Network.
September 11, 2018
Three leading oncology practices unite with partners in technology and finance to announce the launch of OneOncology, a patient-centric, physician-driven, and technology-powered company with a mission to improve the lives of everyone living with cancer.